Your use of this site is subject to our Legal Notice.
Notice of Information Collected
Like many websites, this site collects information from its visitors. Some information that you submit may be personally identifiable information (that is, information that can be uniquely identified with you, such as your full name, address, email address, phone number and so on).
Some areas of this site may require you to submit information in order for you to benefit from the specified features. You will be informed at the information collection point what information is required.
As you navigate through a website, certain information can be passively collected (that is, gathered without your actively providing the information) using various technologies and means, such as Internet protocol addresses, cookies, Internet tags and navigational data collection.
Except as otherwise stated, the information we collect is used to improve the content of our website and may be used to communicate with you, via email, regular mail or by other means, and to provide you with information that we believe to be of interest to you or that you have requested. In addition, we may use this information for marketing and research purposes. This information is for internal use only.
Transfer of Information Beyond BTG
Access to Information
You may have access to your personal information at any time, to revise, correct or delete it, by contacting BTG. If at any time you do not wish BTG to contact you or if you have any questions concerning our privacy practices, please feel free to contact us.
Protection of Your Personal Information
We take reasonable steps to protect your personally identifiable information as you transmit your information from your computer to our site and to protect such information from loss, misuse and unauthorized access, disclosure, alteration or destruction. You should keep in mind that no Internet transmission is ever 100% secure or error-free. In particular, email sent to or from this site may not be secure, and you should therefore take care in deciding what information you send to us via email. Moreover, where you use passwords, ID numbers or other special access features on this site, it is your responsibility to safeguard them.
Feedback Is Not Personal Information
Data that is not personal (such as feedback, questions, comments, ideas and suggestions) shall be deemed nonconfidential, and BTG shall be free to disclose and use such data without any obligation toward you.
Under no circumstances should you use this website to send BTG confidential or proprietary information. BTG does not want to receive such information.
To report an adverse event or for 24-hour medical information, call 1-844-293-0007.
DigiFab® Digoxin Immune Fab (Ovine) is indicated for the treatment of patients with life-threatening or potentially life-threatening digoxin toxicity or overdose. DigiFab® is not indicated for milder cases of digitalis toxicity.
Important Safety Information
Patients with poor cardiac function may deteriorate secondary to the withdrawal of the inotropic action of digoxin by DigiFab®. Rapid drop in serum potassium concentration may occur after treatment with DigiFab®. Patients with known allergies to sheep protein, papaya, or papain are at higher risk of an anaphylactic reaction. Suicidal ingestion may involve more than one drug. Toxic effects of other drugs or poisons should not be overlooked. The most common adverse reactions (>7%) related to DigiFab® are worsening congestive heart failure (13%), hypokalemia (13%) and worsening atrial fibrillation (7%). Please see full prescribing information, including events, precautions, or warnings.